Self-Monitoring Blood Glucose (SMBG) Devices Market Revenue Projected To Hit $24.17 Billion By 2030 With 8.3% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Self-Monitoring Blood Glucose (SMBG) Devices Market Compare Between 2026 And 2030?
The self-monitoring blood glucose (smbg) devices market has experienced significant growth in recent years. It is anticipated to expand from $16.19 billion in 2025 to $17.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. This historic growth is largely a result of the increasing prevalence of diabetes, enhanced awareness of self-monitoring practices, the expanding adoption of home healthcare, the availability of affordable glucose meters, and improvements in diabetes management guidelines.
The self-monitoring blood glucose (smbg) devices market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $24.17 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.3%. This expansion during the forecast period can be attributed to several factors, including the increasing demand for connected health solutions, rising adoption of continuous glucose monitoring, the broadening of telehealth-based diabetes care, a growing emphasis on preventive healthcare, and increasing investments in digital diabetes management. Prominent trends expected in the forecast period involve the increasing adoption of smart glucose monitoring devices, a rising use of continuous glucose monitoring systems, the growing integration of mobile health applications, an expansion of remote patient monitoring solutions, and an enhanced focus on patient-friendly device design.
Access Your Free Sample Report For In-Depth Market Analysis:
What Primary Drivers Are Shaping The Self-Monitoring Blood Glucose (SMBG) Devices Market?
An increasing incidence of diabetes is anticipated to fuel the expansion of the self-monitoring blood glucose device market in the future. Diabetes is defined as a long-term metabolic condition where the body fails to produce sufficient insulin or utilize it efficiently, resulting in high blood sugar levels that can progressively harm different organs and systems. This increasing prevalence of diabetes is largely attributable to poor dietary habits, which elevate sustained blood sugar levels and incrementally compromise metabolic well-being over time. Self-Monitoring Blood Glucose (SMBG) Devices assist individuals with diabetes by offering a means to monitor blood sugar levels in real-time, facilitating prompt modifications to diet, medication, or physical activity for improved glycemic management. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the NHS identified more than half a million (549,000) new individuals in England facing a risk of developing type 2 diabetes. This raised the overall count of people registered with a GP for non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330. This figure marks a substantial rise when compared to 3,065,825 in 2022, indicating an increase of nearly 20%. Consequently, the growing incidence of diabetes is propelling the expansion of the self-monitoring blood glucose devices market.
What Are The Main Segments Within The Self-Monitoring Blood Glucose (SMBG) Devices Market Segment Structure?
The self-monitoring blood glucose (smbg) devices market covered in this report is segmented –
1) By Product: Self-Monitoring Blood Glucose Meters, Testing Strips, Lancets
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers
3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
Subsegments:
1) By Self-Monitoring Blood Glucose Meters: Traditional Glucose Meters, Smart Glucose Meters
2) By Testing Strips: Standard Testing Strips, Test Strips for Specific Meters
3) By Lancets: Standard Lancets, Safety Lancets
What Trends Are Affecting The Growth Of The Self-Monitoring Blood Glucose (SMBG) Devices Market?
Major companies within the self-monitoring blood glucose (SMBG) devices market are prioritizing the development of innovative solutions, such as continuous glucose monitoring (CGM) systems. This focus aims to address the growing demand for less burdensome glucose tracking, better glycemic management, remote patient oversight, and improved integration with insulin delivery and digital health platforms. CGM systems are wearable sensors that continuously measure interstitial glucose, providing trend data, alerts, and cloud-connected reporting; key features include real-time glucose readings, trend arrows, customizable alarms, and data sharing capabilities. Unlike traditional fingerstick SMBG (glucometers), which require discrete capillary blood samples and offer only point-in-time values, CGMs enable proactive adjustments to therapy and offer richer longitudinal insights that can reduce hypoglycemia risk and improve time-in-range. For instance, in August 2024, Medtronic plc, an Ireland-based medical technology company, launched Simplera CGM. This compact, disposable, all-in-one continuous glucose monitor is designed for easier self-application, real-time glucose sensing, and seamless use with both the InPen smart insulin pen and the MiniMed 780G system, offering users a smaller form factor, simplified wear, and enhanced interoperability that supports continuous visibility for Smart MDI users, redundant sensing for pump users, and overall improved comfort, adherence, and clinical decision-making through continuous glucose trend data integration.
Who Are The Companies Participating In The Self-Monitoring Blood Glucose (SMBG) Devices Market?
Major companies operating in the self-monitoring blood glucose (smbg) devices market are Abbott Laboratories, Bionime Corporation, B Braun Melsungen AG, F Hoffmann La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Senseonics Holdings Inc, AgaMatrix Inc, All Medicus Co Ltd, Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Cnoga Medical Ltd, ForaCare Inc, Infopia Co Ltd, Menarini Diagnostics, Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc, OrSense Ltd, Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc
Get The Full Self-Monitoring Blood Glucose (SMBG) Devices Market Report:
Which Region Has The Greatest Market Share In The Self-Monitoring Blood Glucose (SMBG) Devices Market?
North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the self-monitoring blood glucose (smbg) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Self-Monitoring Blood Glucose (SMBG) Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2026, By The Business Research Company
Continuous Glucose Monitoring Devices Market Report 2026
Blood Glucose Monitoring Systems Market Report 2026
Continous Blood Glucose Monitoring Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
